Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 1542-1544 |
Número de páginas | 3 |
Publicación | Clinical Microbiology and Infection |
Volumen | 27 |
N.º | 10 |
DOI | |
Estado | Publicada - oct 2021 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
Acceder al documento
Otros archivos y enlaces
Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
En: Clinical Microbiology and Infection , Vol. 27, N.º 10, 10.2021, p. 1542-1544.
Producción científica: Contribución a una revista › Artículo › Investigación › revisión exhaustiva
TY - JOUR
T1 - Viral populations of SARS-CoV-2 in upper respiratory tract, placenta, amniotic fluid and umbilical cord blood support viral replication in placenta
AU - Piñana, Maria
AU - Abril, Josep F.
AU - Andrés, Cristina
AU - Silgado, Aroa
AU - Navarro, Alexandra
AU - Suy, Anna
AU - Sulleiro, Elena
AU - Pumarola, Tomàs
AU - Quer, Josep
AU - Antón, Andrés
N1 - Funding Information: This study was supported by the Direcció General de Recerca i Innovació en Salut (DGRIS) Catalan Health Ministry Generalitat de Catalunya through Vall d’Hebron Institut de Recerca (VHIR); European Development Regional Fund (ERDF) “A way to achieve Europe” by Spanish Network for Research in Infectious Diseases ( REIPI RD16/0016/0003 ); and Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business (grant number IDI-20200297 ). J.F.A. benefits from Generalitat de Catalunya (AGAUR) grant (grant number 2017SGR-1455 ). The funder had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. We gratefully acknowledge the authors, originating and submitting laboratories of the sequences from GISAID's EpiCov™ Database on which this research is based. The authors declare that they have no competing interests. Funding Information: This study was supported by the Direcci? General de Recerca i Innovaci? en Salut (DGRIS) Catalan Health Ministry Generalitat de Catalunya through Vall d'Hebron Institut de Recerca (VHIR); European Development Regional Fund (ERDF) ?A way to achieve Europe? by Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/0003); and Centro para el Desarrollo Tecnol?gico Industrial (CDTI) from the Spanish Ministry of Economy and Business (grant number IDI-20200297). J.F.A. benefits from Generalitat de Catalunya (AGAUR) grant (grant number 2017SGR-1455). The funder had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation. We gratefully acknowledge the authors, originating and submitting laboratories of the sequences from GISAID's EpiCov? Database on which this research is based. The authors declare that they have no competing interests.
PY - 2021/10
Y1 - 2021/10
UR - http://www.scopus.com/inward/record.url?scp=85116319905&partnerID=8YFLogxK
U2 - 10.1016/j.cmi.2021.07.008
DO - 10.1016/j.cmi.2021.07.008
M3 - Article
C2 - 34260951
AN - SCOPUS:85116319905
SN - 1198-743X
VL - 27
SP - 1542
EP - 1544
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
IS - 10
ER -